Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
H
200670
vs
K
KOSPI 200
Over the past 12 months, Humedix Co Ltd has underperformed KOSPI 200, delivering a return of -49% compared to KOSPI 200's +119% growth.
Stocks Performance
200670 vs KOSPI 200
Performance Gap
200670 vs KOSPI 200
Performance By Year
200670 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Humedix Co Ltd
Glance View
Humedix Co Ltd is a South Korean healthcare company that makes prescription medicines and medical-aesthetic products. Its core products include injectables used in hospitals and clinics, along with skin-related treatments such as dermal fillers and other specialty formulations. In simple terms, it sells products that doctors and medical professionals use for treatment, procedures, and cosmetic care. The company earns money by manufacturing these products and selling them to hospitals, clinics, distributors, and other healthcare customers. Some products are sold under its own brands, while others may be produced for partners or under contract manufacturing arrangements. That mix gives Humedix a business model tied to both pharmaceutical demand and the growing market for non-surgical aesthetic treatments. What makes Humedix different is its position between traditional pharma and beauty-related medicine. It is not a general drugmaker with a broad consumer brand; instead, it focuses on specialized injectable products where quality, formulation know-how, and medical trust matter a lot. That makes it a supplier to healthcare providers rather than a direct-to-consumer company.